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A NARRATIVE REVIEW OF POTENTIAL TREATMENT STRATEGIES FOR FOOD ADDICTION

ABSTRACT
The concept of food addiction (FA) remains controversial with research being in the nascent
stages, FA like any addiction can have a devastating impact upon the lives of those afflicted.
There exists a clinical need for treatment strategies for those affected. This article reviews
potential treatment strategies for FA. The treatment strategies target four core behaviours
of the addiction phenotype specifically craving through the opioid system, impulsivity as a
personality trait, compulsivity through the serotonergic system and lastly motivation
through the dopaminergic system. A range of pharmacological and psychological
interventions are reviewed. Future research should seek to test and validate the proposed
clinical treatment strategies.
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INTRODUCTION
The notion of food addiction (FA) or the potential addictive properties of certain foods for
instance chocolate has long been considered in the general population and the popular
media [1]. In the last decade the phenomenon of FA has received growing academic and
empirical interest [2, 3]. This interest has seen an increased amount of research in the area
along with the development and validation of a specific scale to measure the phenomenon
based upon the substance dependence criteria in the DSM-IV [4]; the Yale Food Addiction
Scale (YFAS) [5].
Although interest in the phenomenon of FA has increased the notion of FA remains
controversial [6]. At the most fundamental level the concept of FA suffers from a lack of
conceptual clarity with researchers failing to explicitly define the concept [7]. FA is
commonly paralleled to that of drug addiction which is an addiction to an exogenous
substance. As such if this is the case the implicated substance/s or in this case nutrients or
food additives are yet to be determined [8].
However, many researchers broadly implicate highly processed foods which contain high
combinations of sugar, salt and/or fat as being responsible for FA [8-10]. With the terms
palatable and hyperpalatable food commonly being utilised to describe these foods [11].
While some suggest that sugar may be addictive in humans having found that rats under
certain conditions display addictive-like eating behaviour towards sucrose [12, 13]. Others
contend that there is no evidence that sugar is addictive in humans [14]. Alternatively
Cocores and Gold [15] maintain that salt in food has an addictive potential as it produces a
hedonic feeling of reward as it acts like an opiate agonist in the brain.
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Moreover others assert that it is not hyperpalatable food per se that promotes addictive like
eating, it is the schedule under which it is consumed; that is a restrictive and subsequent
binge consumption paradigm that results in promoting addictive like eating behaviours [16–
18]. Thus although the concept of FA is commonly described as being akin to drug addiction
in practice it is treated by researchers as laying anywhere on a continuum between an
exogenous and endogenous addiction. Furthermore it is unclear whether it is an addiction in
the sense of drug addiction (exogenous), a behavioural addiction or even an eating disorder
[19].
Recently Hebebrand and colleagues [19] concluded that although research pertaining to FA
is still in the early stages there is enough empirical evidence in both animals and humans to
support the idea that a phenomenon of addictive like eating exists. However they contend
that the use of the term FA is misleading and the phenomenon would be better understood
by the term eating addiction or even as an addictive eating disorder [19].
Thus the phenomenon in accordance with Hebebrand and colleagues [19] is more closely
aligned to a behavioural addiction. However as eating is necessary for survival and as such
fulfils a homeostatic drive this potentiates the opportunity for endogenous compounds to
have a role in addictive like eating behaviour. Albayrak, Wolfe and Hebebrand [20] contend
that endogenous chemicals may be the link between drug and behavioural addictions.
In addition to the shortcomings of the FA concept pertaining to the definition and aetiology
outlined above, others have highlighted that the concept is impeded by its own
measurement [11]. That is the construct of FA according to some has become synonymous
with the measure that was developed to measure it, the YFAS which it is also based upon.
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That is some ascertain the explanation for the existence of the FA concept is circular and
research needs to move beyond the bounds of the YFAS [11].
Further the YFAS has been criticised as being a measure of eating behaviour as oppose to a
measure of FA [19]. Moreover some have ascertained that the YFAS is not accounting for
any additional variance above and beyond that captured by measures of binge eating
behaviour [11]. Others such as Ziauddeen, Farooqi and Fletcher [6] have emphasised the
inconsistencies between FA, overweight, obesity and binge eating also suggesting that binge
eating may better account for the phenomenon. Highlighting the common misconception of
treating overweight and obesity as a homogenous disorder when overweight and obesity
are truly heterogeneous in nature [6]. Furthermore it has even been suggested that FA is a
sub-type of binge eating disorder (BED) and that bulimia nervosa is an extreme form of BED
[11].
Nonetheless interest in the phenomenon continues to grow; with interest further
heightened since the inclusion of the first behavioural addiction; gambling disorder in the
DSM-5 [21]. As traditionally the term addiction has been reserved to describe dependence
upon certain drugs of abuse. That is the term addiction has historically been aligned with
addiction to exogenous substances. This reconceptualization of addiction potentiates the
opportunity for other addictions including behavioural addictions to be considered and
included in future editions of the DSM. Thus FA could possibly be added to the DSM in the
future.
In accordance with the changes related to addiction in the DSM-5 recently Gearhardt and
colleagues [22] released an updated version of the YFAS; the YFAS 2.0. Although the authors
reported that the scale seems to have sound psychometric properties the scale being newly
4

developed requires further comprehensive testing and validation before definitive
conclusions can be drawn.
In parallel to these developments the overweight and obesity epidemic has continued to
rise [23]. Recently Hendrie and colleagues’ [24] calculated projected estimates of the
average body mass index (BMI) by 2019 for both Australian males and females with the
averages being 28.0kg/m2 and 27.6kg/m2 respectively. Further the prevalence of obesity is
expected to rise 6 to 7 percentage points by 2019 with 28.7% of males and 29.2% of females
anticipated to be obese [24].
Thus although the phenomenon of FA is controversial; research remains in the nascent
phase and as such in the context of the worldwide growing obesity epidemic further work is
required. Therefore this article seeks to review potential strategies for the treatment of FA
based upon treating core addiction phenotypic behaviours in the context of addictive like
eating.
This will allow the exploration of the concept of FA beyond the bounds dictated by the YFAS
which is one of the issues with the phenomenon that was outlined above. It will also
facilitate a greater understanding of the concept in relation to disorders associated with
binge eating; thus allowing identification of potential differences and similarities between
the concepts. Moreover and most fundamentally this interventionist paradigm offers utility
for the treatment of addictive like eating behaviour which clearly exists regardless of the
designation granted and as such has the potential to assist with combatting a portion of the
overweight and obesity epidemic.
The Addiction Phenotype:
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Addiction is a debilitating neuropsychiatric disorder that is commonly identified through
behavioural symptoms [25]. The concept of addiction represents a synthesis of dependence
and compulsion. Thus four key addiction behaviours commonly associated with the
addiction phenotype have been selected as the focus for the development of clinical
guidelines for the treatment of food addiction. These four core behaviours are craving,
impulsivity, compulsivity and motivation.
The use of phenotypic behaviours associated with addiction as oppose to clinical criteria
facilitates the understanding of the FA phenomenon beyond the bounds dictated by the
YFAS as mentioned above. As well as overcoming a common issue associated with addiction
criteria; the use of consequences as the basis of the criteria [26]. Below each of the four
core addiction behaviours and their proposed treatment targets are discussed.

Behaviour: Craving
Craving is a hallmark feature of addiction with individuals’ with drug addiction commonly
reporting very strong cravings for the substance they are addicted too [27, 28]. The concept
of craving has been prominent in various models of addiction specifically conditioningbased, cognitive, psychobiological and motivational models of addiction for decades [28].
The constant cravings can impede the individual’s attempts to give up the substance leading
to repeated failures and relapses [27, 28]. In regards to food; human weight cycling is
indicative of repeated attempts and failures related to controlling weight and the intake of
certain foods [27].
Food cravings have been found to be stronger in individuals with BED in comparison to
individuals without BED and with similar BMIs [27]. Further research has also indicated
6

differences between obese individuals’ with and without BED in regards to genotype,
specifically; significant differences in frequencies of opiod and dopamine polymorphisms
have been found between the two groups [29]. Clark [30] ascertains that both binge eating
and obesity predispose individuals to have a strong bias towards immediate gratification; as
such driving craving and consummatory seeking behaviours. In regards to food and
overeating these existing biases are further heightened by the obesigenic environment [30].
The opioid system has direct involvement in both drug and FA [18]. The opioid system plays
a central role in the rewarding properties of hedonically pleasing stimuli [18]. This
reinforcement stems directly from the activation of the opioid system as well as the indirect
activation of the mesolimbic dopamine pathway [18]. Thus the opioid and dopamine
systems work collectively in reinforcing hedonically pleasing stimuli [18].
The opioid system is known to be directly involved in consummatory aspects of behaviour
such as hedonic eating or the intake of drugs of abuse [31]. Recent research has pointed to
the role of the opiate system in anticipatory aspects of ingestive behaviour as well. That is
the opiate system appears to moderate the influence of food-related stimuli and the
motivation for food seeking behaviour [31]. In the context of individuals with BED and / or
obesity such individuals have been found to be more sensitive to environmental food
associated cues thus driving the craving (anticipatory) and subsequent reward seeking
behaviour (consummatory) [31].

Treatment Target: Opiate system
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In order to assist individuals in dealing with the strong cravings associated with addiction a
number of pharmaceutical treatments have been developed; these treatments target the
opiod system[18, 31]. In relation to addictive like eating these treatments have been trialled
with patients with BED and / or obesity.
Randomised trials have investigated the use of a number of anti-craving and anti-addiction
medications in the treatment of BED [32]. The results have been mixed however the use of
the opioid antagonist intranasal spray Naloxone has shown some promise with a significant
reduction in the time spent binge eating for the group using the Naloxone spray in
comparison to those using the placebo spray [32].
Recently Mason and colleagues [33] trialled the use of naltrexone; an anti-addiction
medication commonly utilised in opiod and alcohol addiction with a group of obese women
to negate cravings associated with addictive like eating. The results indicated that reported
craving intensity did not differentiate between the naltrexone and placebo conditions.
However there was some evidence that the opioidergic blockade decreased the association
between the reward driven eating and daily food craving intensity [33].
In addition, as overcoming an addiction requires an individual to be able to cope with
negative emotions and cravings; it has been suggested that treatments that target emotion
regulation and distress tolerance are pivotal to the treatment of both drug addiction and
BED [27]. Thus the psychological treatments of motivational interviewing and CBT are
utilised to assist abstinence motivation, emotion regulation and the development of specific
coping strategies [34]. These techniques can be utilised independently or in collaboration
with a pharmaceutical treatment.
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Behaviour: Impulsivity
Impulsivity is a personality trait that is associated with multiple psychiatric disorders [35].
Impulsivity is defined as “acting on the spur of the moment without thinking, planning, or
considering the consequences” [36]. The trait of impulsivity is a known risk factor for the
development of multiple addictions [6, 36, 37].
Impulsive intake of a substance in this context food; is associated with a loss of control [34].
Moreover the propensity to act impulsively in relation to food has been implicated as a
potential factor contributing to obesity [38]. A recent review found increased impulsivity in
relation to reward sensitivity in obese individuals that was further heightened in individuals
with BED [38].
Studies in obese subjects with and without BED have indicated deficits in decisional
impulsivity specifically in regards to delay discounting and risk taking in the context of
ambiguity indicating a potential deficit as a function of obesity [37]. Further this deficit
appears to be mediated by the level of obesity and the context of the food cues [37].
Motor impulsivity (motor response inhibition or waiting impulsivity) seems to be more
impaired in obese subjects with BED than obese non-BED controls in relation to food related
stimuli but not neutral stimuli [37]. More widespread impairments generally apparent in
other addictions in relation to impulsivity were not evident in obesity and obesity coupled
with BED [37].
Treatment Target: Trait of Impulsiveness
Impulsivity appears to be a predisposing trait to addiction with the personality trait initially
driving the behaviour and the start of the addiction [39, 40]. Impulsivity can also be a
9

consequence of addiction with chronic substance use leading to further elevated levels of
impulsivity, recent research also indicates a similar relationship between impulsivity and
behavioural addictions [41]. Moreover impulsivity is also related to treatment outcomes and
time to relapse [42, 43] Thus the primary treatment target is the trait of impulsivity.
Psychological treatments such as CBT and group therapy aimed at increasing mindfulness
and awareness, along with the acceptance and tolerance of emotions are known to assist
with negating impulsivity in substance use disorders [42]. Specifically mindfulness assists as
awareness is focused upon the present moment and environment which helps to
circumvent automated and impulsive behaviours [42]. Further treatments that foster
problem-solving and decision making skills are also beneficial [27].
Moreover treatments that specifically focus upon cue and reward sensitivity in addiction are
also effective in assisting impulse control [44]. A recent review of both human and animal
studies indicated increased cue reactivity in a subset of individuals as being the impetus for
impulsive behaviour [44]. Therefore treatments focused upon teaching individuals with
addiction to avoid attending too or extinguishing the salience of cues has proven efficacious
[44].
In addition to psychological therapies there are pharmaceutical treatments that assist with
controlling impulsivity. In relation to FA, lisdexamfetamine dimesylate has proven effective
in the treatment of BED [45]. Lisdexamfetamine dimesylate is the only drug with FDA
approval to treat BED [45]. A recent study by McElroy and colleagues [45] found that
lisdexamfetamine dimesylate reduced impulsivity, binge eating severity as well as total
binge eating days in patients with BED.
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Behaviour: Compulsivity
Compulsivity and impulsivity are related constructs that are thought to involve
corresponding processes and the same underlying neural substrates [37]. Models of
addiction posit that impulsivity and compulsivity lie at opposing ends of a continuum; that is
impulsivity drives the initial process leading to addiction where upon compulsive behaviours
take over and the behaviour is continued regardless of the negative consequences [37].
Compulsivity is associated with repeating a specific behaviour regardless of the negative
consequences [37]. Research has shown that subjects with BED display impairments across
multiple domains of compulsivity in comparison to obese controls [37]. However the level of
these deficits appears to be a function of BMI with subjects with and without BED and
higher BMIs displaying similar impairments [37].
Kenny [46] after completing a review of the common neural mechanisms that underlie both
the over consumption of hyperpalatable food and drugs of abuse concluded that there is
enough evidence to view obesity as a ‘compulsive consummatory behaviour’ akin to drug
addiction. As such obesity and binge eating in particular can be understood as a compulsive
behaviour.
Another disorder that manifests compulsive behaviour is obsessive compulsive disorder
(OCD) with dysfunction in the serotonergic system thought to be central to the disorder
[47]. Therefore treatments aimed at the behaviour of compulsivity should target the
serotonergic system.
Treatment Target: Serotonin system
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The ideology of compulsive eating and a loss of control in regards to food consumption is
central to the phenomenon of FA. Thus as noted above the serotonergic system is a
common treatment target in another disorder that involves compulsivity; OCD and selective
serotonin reuptake inhibitors (SSRIs) have also been utilised in the treatment of BED.
Recently Berkman and colleagues [48] conducted a systematic review and meta-analysis of
the management of BED. They concluded that second generation antidepressants are
superior to placebo in reducing eating related obsessions and compulsions and reducing
binge eating episodes. Further they also reduced depressive symptomology a common
comorbid condition with BED [48]. SSRIs have also shown some effectiveness in treating
binge eating and purging in bulimia nervosa [32].
Although not targeting the serotonergic system recently Hurley and colleagues [49] found
that N-acetylcysteine decreased binge eating in the animal model. N-acetylcysteine is a
prodrug that acts upon the glutamate and dopamine neurotransmission [50]. Although data
is limited N-acetylcysteine has also shown promise in the treatment of addictions including
gambling disorder as well as OCD; reducing compulsive behaviours in these disorders [50].
In addition to pharmaceutical treatments psychotherapeutic interventions are also
recommended. In regards to compulsive eating similarly to the psychological treatments for
other core addiction behaviours stimulus control and effective coping strategies are
implicated [27]. Such as avoiding hyperpalatable foods that could lead to compulsive
overeating and finding alternatives for pleasure and reward [27].
Behaviour: Motivation
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As oppose to drugs of abuse the degree to which food is rewarding is moderated by
homeostatic mechanisms driven by the current level of hunger of the individual [34]. Thus
food can be consumed for energetic reasons as well as the foods own reinforcing
(rewarding) properties [34]. Studies pertaining to the neural peptides leptin, ghrelin and
orexin support a close link between the homeostatic and motivational systems [34]. Studies
have indicated that during periods of hunger the motivational system directs attention
towards food and food related stimuli [34].
The mesolimbic dopamine system has a known role in reward processing, reward
reinforcement and attending to motivationally salient stimuli [18]. In addiction, drugs of
abuse directly impact upon the mesolimbic dopaminergic system with drugs of abuse and
associated stimuli elevating dopamine levels in the striatum. In FA hyperpalatable foods and
food associated cues have a similar effect on dopamine levels in the striatum [18]. Thus the
mesolimbic dopaminergic system plays a pivotal role in motivation.
Treatment Target: Dopamine system
Drugs of abuse are known to impact upon striatal dopamine receptor availability and striatal
function, recently Gearhardt and colleagues [9] reported that obesity in humans is also
associated with a reduction in striatal dopamine receptor availability and striatal
dysfunction.

Further research preceding addiction has also shown that individuals

vulnerable to developing an addiction have a pre-existing decrease in striatal dopamine D2
receptor availability [18]. This renders individuals as being more predisposed to the
rewarding properties of desirable stimuli and as such the potentially rewarding stimuli is
more salient [18].
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Grosshans, Loeber and Kiefer [34] report that there is evidence that pharmacotherapy
developed for the treatment of addiction specifically relapse prevention in addiction is also
effective in the treatment of obesity.

These treatments all target the dopaminergic

mesolimbic system [34].
Recent years have seen the development of psychological treatment options for addiction
such as motivational interviewing and cognitive behavioural therapy (CBT) to bolster
abstinence motivation and assist with strategies to alleviate the possibility of relapse [34].
These treatments target the cognitive focus upon the rewarding stimuli either directly or
indirectly through the addition of an alternative reinforcer; hence these therapeutic options
target the mesolimbic reward system [34]. Further CBT and interpersonal therapy although
efficacious in the short and long-term reduction of binge eating in BED are not associated
with clinically significant weight loss rather they alleviate the potential to gain further
weight through continued binge eating [51].
Conclusion:
This article sought to review potential strategies for the treatment of FA based upon four
core behaviours of the addiction phenotype. To our knowledge this is the first review of
clinical treatment strategies directly aimed at targeting FA. The reviewed treatments target
addictive like eating through core behaviours synonymous with addiction generally. Namely;
targeting craving through the opiod system, targeting impulsivity as a personality trait,
targeting compulsivity through the serotonergic system and lastly targeting motivation
through the dopaminergic system.
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It is thought that utilising these treatment strategies should assist with alleviating addictive
like eating behaviours. It is intended that these treatments would be utilised to provide
individualised treatment. That is targeting addictive like eating through the most prominent
and worrying behaviour or behaviours for each individual. Therefore treatment could be
targeted at a single behavioural domain or at multiple domains. Further treatment could be
solely pharmacological or psychological, or both could be utilised in combination to target a
single or multiple behaviours.
Although the notion of individualised treatment was a primary tenet underlying this review
of potential treatment strategies, the strategies espoused are sufficiently general so they
are applicable to the broader population struggling with addictive like eating. With the
inclusion of the four general addiction specific behaviours being broad enough to facilitate
wide-ranging treatment of addictive like eating in the larger population as well as diverse
population segments. The development of these potential treatment strategies although
not yet validated offer both an opportunity to view the phenomenon of FA from an
alternate perspective beyond that delineated in YFAS as well as offering a potential
approach to the treatment of addictive like eating.
Research pertaining to FA in general is in the nascent stage and as such further work is
needed in order to better understand the phenomenon. Specifically further research should
focus upon the measurement, course and treatment of FA, as well as the most appropriate
designation for the construct. In addition better methods for the assessment of
psychological, behavioural and psychosocial variables that are related to FA are required.
Specifically in relation to the espoused treatment strategies extensive testing and validation
is required to elucidate whether they are effective in negating FA behaviours in the general
15

affected population as well as in diverse population segments. Further research should also
seek to ascertain the most effective methods and modes of assessment to delineate the
specific behaviour or behaviours to be targeted which would inform individualised
treatment.
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